1. Home
  2. VLO vs BSX Comparison

VLO vs BSX Comparison

Compare VLO & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valero Energy Corporation

VLO

Valero Energy Corporation

HOLD

Current Price

$352.24

Market Cap

77.3B

Sector

Energy

ML Signal

HOLD

Logo Boston Scientific Corporation

BSX

Boston Scientific Corporation

HOLD

Current Price

$46.84

Market Cap

65.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VLO
BSX
Founded
1980
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Integrated oil Companies
Medical/Dental Instruments
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
77.3B
65.8B
IPO Year
1997
2010

Fundamental Metrics

Financial Performance
Metric
VLO
BSX
Price
$352.24
$46.84
Analyst Decision
Buy
Strong Buy
Analyst Count
18
22
Target Price
$232.17
$93.18
AVG Volume (30 Days)
2.3M
18.5M
Earning Date
04-30-2026
04-22-2026
Dividend Yield
1.91%
N/A
EPS Growth
N/A
55.20
EPS
16.78
1.51
Revenue
$122,687,000,000.00
$9,076,000,000.00
Revenue This Year
$9.62
$11.85
Revenue Next Year
N/A
$10.16
P/E Ratio
$20.65
$30.88
Revenue Growth
N/A
12.49
52 Week Low
$151.25
$42.20
52 Week High
$353.00
$109.50

Technical Indicators

Market Signals
Indicator
VLO
BSX
Relative Strength Index (RSI) 65.78 44.32
Support Level $292.79 $42.32
Resistance Level N/A $50.14
Average True Range (ATR) 9.54 1.53
MACD -0.64 -0.57
Stochastic Oscillator 86.22 8.31

Price Performance

Historical Comparison
VLO
BSX

About VLO Valero Energy Corporation

Valero Energy is one of the largest independent refiners in the United States. It operates 15 refineries, with a total throughput capacity of 3.2 million barrels a day in the US, Canada, and the United Kingdom. Valero also owns 12 ethanol plants with capacity of 1.6 billion gallons a year and holds a 50% stake in Diamond Green Diesel, which can produce 1.2 billion gallons per year of renewable diesel.

About BSX Boston Scientific Corporation

Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.

Share on Social Networks: